Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-23T10:33:20.800Z Has data issue: false hasContentIssue false
  • English
  • Français

The association between prostate cancer and mood disorders: a nationwide population-based study in Taiwan

Published online by Cambridge University Press:  22 October 2014

Pan-Ming Chen ,
San-Chi Chen ,
Chia-Jen Liu ,
Man-Hsin Hung ,
Chia-Fen Tsai ,
Yu-Wen Hu ,
Mu-Hong Chen ,
Cheng-Che Shen ,
Tung-Ping Su  and
Chiu-Mei Yeh
...Show all authors
Pan-Ming Chen
Affiliation:
Department of Psychiatry, Yuanshan Branch, Taipei Veterans General Hospital, Yilan, Taiwan
San-Chi Chen
Affiliation:
Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Chia-Jen Liu
Affiliation:
Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan Institute of Public Health & School of Medicine, National Yang-Ming University, Taipei, Taiwan
Man-Hsin Hung
Affiliation:
Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Chia-Fen Tsai
Affiliation:
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan School of Medicine, National Yang-Ming University, Taipei, Taiwan
Yu-Wen Hu
Affiliation:
Cancer Center, Taipei Veterans General Hospital, Taipei, Taiwan
Mu-Hong Chen
Affiliation:
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan
Cheng-Che Shen
Affiliation:
Department of Psychiatry, Chiayi Branch, Taichung Veterans General Hospital, Chiayi, Taiwan
Tung-Ping Su
Affiliation:
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan School of Medicine, National Yang-Ming University, Taipei, Taiwan
Chiu-Mei Yeh
Affiliation:
Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Ti Lu
Affiliation:
Department of Psychiatry, Kaohsiung Veterans General Veterans Hospital, Kaohsiung City, Taiwan
Tzeng-Ji Chen
Affiliation:
School of Medicine, National Yang-Ming University, Taipei, Taiwan Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Li-Yu Hu*
Affiliation:
Department of Psychiatry, Kaohsiung Veterans General Veterans Hospital, Kaohsiung City, Taiwan
*
Correspondence should be addressed to: Li-Yu Hu, M.D. Department of Psychiatry, Kaohsiung Veterans General Veterans Hospital, Taiwan 386, Ta-Chung 1st Rd., Tzuo-Yin Dist., Kaohsiung City 81362, Taiwan. Phone: +886-7-3422121; Fax: +886-7-3468346. Email: [email protected].
Get access

Abstract

Background:

This study identified possible risk factors for newly diagnosed mood disorders, including depressive and bipolar disorders, in prostate cancer patients.

Methods:

From 2000 to 2006, two cohorts were evaluated on the occurrence of mood disorder diagnosis and treatment. For the first cohort, data of patients diagnosed with prostate cancer was obtained from the Taiwan National Health Insurance (NHI) Research Database. As the second cohort, a cancer-free comparison group was matched for age, comorbidities, geographic region, and socioeconomic status.

Results:

Final analyses involved 12,872 men with prostate cancer and 12,872 matched patients. Increased incidence of both depressive (IRR 1.52, 95% CI 1.30–1.79, P <0.001) and bipolar disorder (IRR 1.84, 95% CI 1.25–2.74, P = 0.001) was observed among patients diagnosed with prostate cancer. Multivariate matched regression models show that cerebrovascular disease (CVD) and radiotherapy treatment could be independent risk factors for developing subsequent depressive and bipolar disorders.

Conclusion:

We observed that the risk of developing newly diagnosed depressive and bipolar disorders is higher among Taiwanese prostate cancer patients. Clinicians should be aware of the possibility of increased depressive and bipolar disorders among prostate cancer patients in Taiwan. A prospective study is necessary to confirm these findings.

Keywords

depressionbipolar disorderprostate cancerrisk factorepidemiology
Type
Research Article
Information
International Psychogeriatrics , Volume 27 , Issue 3 , March 2015 , pp. 481 - 490
Copyright
Copyright © International Psychogeriatric Association 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abbott, N. J., Ronnback, L. and Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience, 7, 41–53.Google Scholar
American Cancer Society (2013). Cancer Facts & Figures 2013. Avalibale at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf; last accessed 20 April 2014.Google Scholar
Bailey, R. K., Geyen, D.J., Scott-Gurnell, K., Hipolito, M.M., Bailey, T.A. and Beal, J. M. (2005). Understanding and treating depression among cancer patients. International Journal of Gynecological Cancer, 15, 203–208.Google Scholar
Bill-Axelson, A. et al. (2010). Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden. European Urology, 57, 390–395.Google Scholar
Bill-Axelson, A. et al. (2011). Psychiatric treatment in men with prostate cancer–results from a Nation-wide, population-based cohort study from PCBaSe Sweden. European Journal of Cancer, 47, 2195–2201.Google Scholar
Brintzenhofe-Szoc, K. M., Levin, T. T., Li, Y., Kissane, D. W. and Zabora, J. R. (2009). Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics, 50, 383–391.Google Scholar
Cherrier, M. M., Aubin, S. and Higano, C. S. (2009). Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psychooncology, 18, 237–247.Google Scholar
Chochinov, H. M. (2001). Depression in cancer patients. The Lancet Oncology, 2, 499–505.Google Scholar
De Marzo, A. M. et al. (2007). Inflammation in prostate carcinogenesis. Nature Reviews Cancer, 7, 256–269.Google Scholar
Fall, K. et al. (2009). Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Medicine, 6, e1000197.Google Scholar
Fang, F. et al. (2010). Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. Journal of the National Cancer Institute, 102, 307–314.Google Scholar
Hu, L. Y. et al. (2013). Hyperthyroidism and risk for bipolar disorders: a nationwide population-based study. PLoS One, 8, e73057.Google Scholar
Huang, K. L., Su, T. P., Chen, T. J., Chou, Y. H. and Bai, Y. M. (2009). Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study. Psychiatry and Clinical Neurosciences, 63, 401–409.Google Scholar
Khan, A. Y., Ludvigson, L. R., Stewart, M. and Gorman, J. M. (2007). Menopause manifesting as bipolar symptoms. Journal of Psychiatric Practice, 13, 339–342.Google Scholar
Khan, N. F., Perera, R., Harper, S. and Rose, P. W. (2010a). Adaptation and validation of the Charlson index for read/OXMIS coded databases. BMC Family Practice, 11, 1.Google Scholar
Khan, N. F., Ward, A. M., Watson, E. and Rose, P. W. (2010b). Consulting and prescribing behaviour for anxiety and depression in long-term survivors of cancer in the UK. European Journal of Cancer, 46, 3339–3344.Google Scholar
Lajeunesse, C., Parent, R. and Villeneuve, A. (1986). Manic-like episode following flutamide treatment. The American Journal of Psychiatry, 143, 1498–1499.Google Scholar
Lin, H. P., Deng, C. Y. and Chou, P. (2009). Diagnosis and treatment delay among pulmonary tuberculosis patients identified using the Taiwan reporting enquiry system, 2002–2006. BMC Public Health, 9, 55.Google Scholar
Lintz, K. et al. (2003). Prostate cancer patients’ support and psychological care needs: survey from a non-surgical oncology clinic. Psycho-oncology, 12, 769–783.Google Scholar
Maggio, M. et al. (2006). Circulating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapy. Journal of Andrology, 27, 725–728.Google Scholar
McCarron, S. L. et al. (2002). Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Research, 62, 3369–3372.Google ScholarPubMed
Munkholm, K., Vinberg, M. and Vedel Kessing, L. (2013). Cytokines in bipolar disorder: a systematic review and meta-analysis. Journal of Affective Disorders, 144, 16–27.Google Scholar
Pfitzenmaier, J., Vessella, R., Higano, C.S., Noteboom, J.L., Wallace, D. Jr. and Corey, E. (2003). Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer, 97, 1211–1216.Google Scholar
Pu, Y., Chiang, H., Lin, C., Huang, C., Huang, K. and Chen, J. (2004). Changing trends of prostate cancer in Asia. The Aging Male, 7, 120–132.Google Scholar
Seidman, S. N. et al. (2002). Low testosterone levels in elderly men with dysthymic disorder. American Journal of Psychiatry, 159, 456–459.CrossRefGoogle ScholarPubMed
Sharpley, C. F., Bitsika, V. and Christie, D. R. (2012). Do patient-reported androgen-deprivation therapy side effects predict anxiety and depression among prostate cancer patients undergoing radiotherapy? Implications for psychosocial therapy interventions. Journal of Psychosocial Oncology, 30, 185–197.Google Scholar
Sher, L. et al. (2012). Testosterone levels in suicide attempters with bipolar disorder. Journal of Psychiatric Research, 46, 1267–1271.Google Scholar
Steineck, G. et al. (2002). Quality of life after radical prostatectomy or watchful waiting. New England Journal of Medicine, 347, 790–796.Google Scholar
Townsend, L., Walkup, J. T., Crystal, S. and Olfson, M. (2012). A systematic review of validated methods for identifying depression using administrative data. Pharmacoepidemiology and Drug Safety, 21, 163–173.Google Scholar
Van Onselen, C. et al. (2010). Relationship between mood disturbance and sleep quality in oncology outpatients at the initiation of radiation therapy. European Journal of Oncology Nursing, 14, 373–379.Google Scholar
van Tol-Geerdink, J. J., Leer, J. W., van Lin, E. N., Schimmel, E. C. and Stalmeier, P. F. (2011). Depression related to (neo)adjuvant hormonal therapy for prostate cancer. Radiotherapy Oncology, 98, 203–206.Google Scholar
Wiechno, P. J., Sadowska, M., Kalinowski, T., Michalski, W. and Demkow, T. (2013). Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life? Psychooncology, 22, 346–351.Google Scholar
Wu, C. S., Wang, S. C., Cheng, Y. C. and Gau, S. S. (2011). Association of cerebrovascular events with antidepressant use: a case-crossover study. American Journal of Psychiatry, 168, 511–521.Google Scholar